February 16, 2022
Breakthrough T1D congratulates Tandem Diabetes Care on the FDA clearance of the t:slim X2™ insulin pump using the t:connect® mobile app. This announcement is the first step in creating a new normal in using technology to ease bolus insulin dosing for pump users. Breakthrough T1D has been a longtime funder of the technological research and clinical trials which have led to today’s announcement, and we are proud to celebrate this with the community.
-Breakthrough T1D International
